Your browser doesn't support javascript.
loading
Effectiveness of Nivolumab in Second-Line and Later in Patients with Advanced Non-Small Cell Lung Cancer in Real-Life Practice in France and Germany: Analysis of the ESME-AMLC and CRISP Cohorts.
Chouaid, Christos; Thomas, Michael; Debieuvre, Didier; Durand-Zaleski, Isabelle; Zacharias, Stefan; Bosquet, Lise; Groth, Annika; Fleitz, Annette; Calleja, Alan; Patel, Sonya; Lacoin, Laure; Daumont, Melinda J; Penrod, John R; Carroll, Robert; Waldenberger, Daniela; Cotté, François-Emery; Audigier-Valette, Clarisse; Griesinger, Frank.
Affiliation
  • Chouaid C; Pneumology Unit, Centre Hospitalier Intercommunal de Créteil, 40 Avenue de Verdun, 94000 Créteil, France.
  • Thomas M; Translational Lung Research Center Heidelberg (TLRC-H), Member of the German Center for Lung Research (DZL), 69126 Heidelberg, Germany.
  • Debieuvre D; Thoraxklinik and National Center for Tumor Diseases at Heidelberg University Hospital, Röntgenstr. 1, 69126 Heidelberg, Germany.
  • Durand-Zaleski I; Chest Disease Department, GHRMSA-Emile Muller Hospital, 68070 Mulhouse, France.
  • Zacharias S; AP-HP Health Economics Research Unit, Hotel Dieu Hospital, INSERM UMR 1153 CRESS, Clinical Epidemiology (Methods) Research Team, 75004 Paris, France.
  • Bosquet L; Department of Biostatistics, iOMEDICO, Ellen-Gottlieb-Straße 19, 79106 Freiburg, Germany.
  • Groth A; Health Data and Partnerships Department, Unicancer, 101 Rue de Tolbiac, CEDEX 13, 75654 Paris, France.
  • Fleitz A; AIO-Studien-gGmbH, Kuno-Fischer-Str. 8, 14057 Berlin, Germany.
  • Calleja A; Clinical Epidemiology and Health Economics, iOMEDICO, Ellen-Gottlieb-Straße 19, 79106 Freiburg, Germany.
  • Patel S; Real World Solutions, IQVIA, The Point, 37 North Wharf Road, London W2 1AF, UK.
  • Lacoin L; Real World Solutions, IQVIA, The Point, 37 North Wharf Road, London W2 1AF, UK.
  • Daumont MJ; Epi-Fit, 261 Rue Mandron, 33000 Bordeaux, France.
  • Penrod JR; Worldwide Health Economics & Outcomes Research, Bristol Myers Squibb, Avenue de Finlande 4, 1420 Braine-L'Alleud, Belgium.
  • Carroll R; Worldwide Health Economics & Outcomes Research, Bristol Myers Squibb, 3551 Lawrenceville, Princeton Rd, Princeton, NJ 002627, USA.
  • Waldenberger D; Centre for Observational Research & Data Sciences, Bristol Myers Squibb, Uxbridge Business Park, Sanderson Road, Uxbridge UB8 1DH, UK.
  • Cotté FE; Medical Oncology, Bristol Myers Squibb GmbH & Co. KGaA, Arnulfstraße 29, 80636 Munich, Germany.
  • Audigier-Valette C; Health Economics & Outcomes Research, Bristol Myers Squibb, 3 Rue Joseph Monnier, 92500 Rueil-Malmaison, France.
  • Griesinger F; Department Thoracic Oncology, Centre Hospitalier Toulon Sainte Musse, 54 Rue Henri Sainte Claire Deville, 83056 Toulon, France.
Cancers (Basel) ; 14(24)2022 Dec 13.
Article in En | MEDLINE | ID: mdl-36551632
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Evaluation_studies / Risk_factors_studies Language: En Journal: Cancers (Basel) Year: 2022 Document type: Article Affiliation country: France Country of publication: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Evaluation_studies / Risk_factors_studies Language: En Journal: Cancers (Basel) Year: 2022 Document type: Article Affiliation country: France Country of publication: Switzerland